Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been given an average rating of "Hold" by the seventeen ratings firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $3.95.
A number of equities analysts recently commented on the company. Stifel Nicolaus raised their target price on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Wednesday, February 26th. Sanford C. Bernstein boosted their price objective on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research report on Wednesday, January 15th. Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price on the stock. Finally, Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and boosted their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th.
View Our Latest Stock Analysis on agilon health
agilon health Price Performance
Shares of agilon health stock traded up $0.11 during mid-day trading on Monday, reaching $4.05. 3,669,360 shares of the stock traded hands, compared to its average volume of 4,588,132. The business has a 50-day moving average of $3.22 and a 200 day moving average of $2.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.67 billion, a PE ratio of -4.27 and a beta of 0.67. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.
Insider Activity at agilon health
In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On agilon health
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC acquired a new position in agilon health during the third quarter worth approximately $513,000. Aigen Investment Management LP bought a new position in shares of agilon health during the 3rd quarter worth approximately $79,000. Simplify Asset Management Inc. increased its holdings in shares of agilon health by 67.5% during the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company's stock worth $663,000 after acquiring an additional 67,968 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of agilon health during the 3rd quarter worth approximately $228,000. Finally, Citigroup Inc. raised its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period.
agilon health Company Profile
(
Get Free Reportagilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.